https://pubmed.ncbi.nlm.nih.gov/24823696/?dopt=Abstract
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a...
AXIS data suggest that longer duration of the first-line therapy generally yields better outcome with the second-line therapy and that lack of response to...
https://pmc.ncbi.nlm.nih.gov/articles/PMC10831538/
A review of CONCEPTT study findings including subanalyses in pregnant women using continuous...
The main objective of this article is to provide a comprehensive review of continuous glucose monitor (CGM) use in pregnant women with type 1 diabetes (T1D)...